2002
Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370
Ickovics J, Cameron A, Zackin R, Bassett R, Chesney M, Johnson VA, Kuritzkes DR, Acosta E, Barnett R, Bell D, Cannmann S, Eron J, Fischl M, Marschner I, Martinez A, Morse G, Pettinelli C, Sommadossi J, Wood K, Murphy R, Priller N, Sha B, French N, van der Horst C, Marcus C, Lane T, Horton J, Schooley R, Putnam B, Shugarts D, Johnson S, Fife K, Black J, Heise D, Todd K, Bagur J, Vazquez G, Lopez I, Ramirez V, Hill R, Wright S, McCulloch B, Saag M, Slamowitz D, Cain P, Merigan T, Tallman V, Greisberger C, Shoemaker M, Lewis M, Hewitt R, Havlir D, Nuffer K, Wininger D, Watson S, Clark J, Jackson C, Rodriguez A, Scerpella E, Tebas P, Stiffler T, Royal M, Powderly W, Collier A, Storey S, Houseworth L, Conley N, Lederman M, Kalayjian B, Ingersol K, McVey R, Gluckman S, Helker C, Kappes R, Kim D, Albrecht M, Koziol C, Govan; T, Miles S, Chafey S, Mitsuyasu R, Sacks H, Mildvan D, Shikuma C, Millard M, Souza S. Consequences and Determinants of Adherence to Antiretroviral Medication: Results from Adult Aids Clinical Trials Group Protocol 370. Antiviral Therapy 2002, 7: 185-193. PMID: 12487386, DOI: 10.1177/135965350200700308.Peer-Reviewed Original ResearchConceptsPlasma HIV-1 RNA levelsHIV-1 RNA levelsCD4 cell countWeek 24Adherence ratesClinical trialsBaseline plasma HIV-1 RNA levelsAdult AIDS Clinical Trials GroupCell countAIDS Clinical Trials GroupRNA levelsAIDS clinical trialsAdverse clinical eventsAssociation of adherenceOverall adherence rateDeterminants of adherenceClinical Trials GroupSelf-reported adherencePredictors of adherencePatterns of adherenceNon-nucleoside reversePotential confounding variablesVirological outcomesAntiretroviral therapyAdverse events
2001
Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states
Wilson T, Ickovics J, Fernandez M, Koenig L, Walter E, Project F. Self-reported zidovudine adherence among pregnant women with human immunodeficiency virus infection in four US states. American Journal Of Obstetrics And Gynecology 2001, 184: 1235-1240. PMID: 11349194, DOI: 10.1067/mob.2001.114032.Peer-Reviewed Original ResearchConceptsPregnant womenHuman immunodeficiency virus-infected pregnant womenHuman immunodeficiency virus (HIV) infectionPrenatal illicit drug useImmunodeficiency virus infectionPrenatal care settingsIllicit drug useIllicit drug usersPrenatal zidovudineZidovudine dosesZidovudine useZidovudine therapyWeeks' gestationPrenatal vitaminsIncomplete adherencePrenatal clinicsRegimen adherenceVirus infectionCare settingsPsychosocial factorsDrug usersDrug useMultivariate analysisWomenAdherenceBarriers to universal prenatal HIV testing in 4 US locations in 1997.
Royce R, Walter E, Fernandez M, Wilson T, Ickovics J, Simonds R. Barriers to universal prenatal HIV testing in 4 US locations in 1997. American Journal Of Public Health 2001, 91: 727-33. PMID: 11344880, PMCID: PMC1446691, DOI: 10.2105/ajph.91.5.727.Peer-Reviewed Original ResearchConceptsPrenatal HIV testingHIV testingParturient womenPrenatal HIV testProportion of womenMost parturient womenHIV testPrenatal HIVClinician recommendationsPrenatal careProvider practicesStrong recommendationsPrivate insuranceWomenPayment statusMajor barrierMultiple reasonsProportionHIVTestingHospitalCliniciansRecommendationsNew Mothers' Knowledge and Attitudes About Perinatal Human Immunodeficiency Virus Infection
WALTER E, ROYCE R, FERNÁNDEZ M, DEHOVITZ J, ICKOVICS J, LAMPE M. New Mothers' Knowledge and Attitudes About Perinatal Human Immunodeficiency Virus Infection. Obstetrics And Gynecology 2001, 97: 70-76. DOI: 10.1097/00006250-200101000-00015.Peer-Reviewed Original ResearchConceptsPerinatal HIV transmissionPercent of womenHIV transmissionPerinatal transmissionHIV testPerinatal human immunodeficiency virus (HIV) infectionHuman immunodeficiency virus (HIV) infectionHuman immunodeficiency virus (HIV) testingFuture public health effortsHIV test acceptanceNew mothers' knowledgePrenatal HIV testImmunodeficiency virus infectionPrenatal HIV testingPublic health effortsCross-sectional surveyPublic health systemOrigin of HIVPerinatal HIVHIV testingPregnant womenPostpartum womenHours postpartumMothers' knowledgeResults SeventyNew mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection.
Walter E, Royce R, Fernández M, DeHovitz J, Ickovics J, Lampe M. New mothers' knowledge and attitudes about perinatal human immunodeficiency virus infection. Obstetrics And Gynecology 2001, 97: 70-6. PMID: 11152911, DOI: 10.1016/s0029-7844(00)01070-x.Peer-Reviewed Original ResearchConceptsPerinatal HIV transmissionPercent of womenHIV transmissionPerinatal transmissionHIV testPerinatal human immunodeficiency virus (HIV) infectionHuman immunodeficiency virus (HIV) infectionHuman immunodeficiency virus (HIV) testingFuture public health effortsHIV test acceptanceNew mothers' knowledgePrenatal HIV testImmunodeficiency virus infectionPrenatal HIV testingPublic health effortsCross-sectional surveyPublic health systemOrigin of HIVPerinatal HIVHIV testingPregnant womenPostpartum womenHours postpartumMothers' knowledgeVirus infection
2000
Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments
Chesney M, Ickovics J, Chambers D, Gifford A, Neidig J, Zwickl B, Wu A, GROUP P. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000, 12: 255-266. PMID: 10928201, DOI: 10.1080/09540120050042891.Peer-Reviewed Original ResearchConceptsAdult AIDS Clinical Trials GroupCent of patientsClinical trialsAntiretroviral therapyAdherence instrumentAIDS Clinical Trials GroupCombination antiretroviral therapyClinical Trials GroupSelf-reported adherenceHIV clinical trialsAdherent patientsAntiretroviral medicationsTrial groupLow adherenceSelf-report questionnairesCommon reasonPatientsDrug resistanceTrialsImproved healthMedicationsProtease inhibitorsQuestionnaireDoseAdherence
1999
Adherence: a necessity for successful HIV combination therapy.
Chesney M, Ickovics J, Hecht F, Sikipa G, Rabkin J. Adherence: a necessity for successful HIV combination therapy. AIDS 1999, 13 Suppl A: s271-8. PMID: 10885784.Peer-Reviewed Original ResearchConceptsCombination therapyHIV/AIDSHIV combination therapySuccessful treatment outcomeEmergence of resistancePatient adherenceClinical trialsDisease progressionLong-term benefitsRisk factorsHIV therapyTreatment outcomesTherapyAdherence researchResistant strainsHealth benefitsAdherenceIntervention programsVirus breakthroughAIDSIntervention effortsDifferent populationsValid methodFocused effortsHIV
1998
Preventive interventions to reduce heterosexual HIV risk for women: current perspectives, future directions.
Ickovics J, Yoshikawa H. Preventive interventions to reduce heterosexual HIV risk for women: current perspectives, future directions. AIDS 1998, 12 Suppl A: s197-208. PMID: 9633004.Peer-Reviewed Original Research
1997
Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection
Ickovics J, Chesney M. Issues Regarding Antiretroviral Treatment for Patients With HIV-1 Infection. JAMA 1997, 278: 1233-1234. PMID: 9333258, DOI: 10.1001/jama.1997.03550150037025.Peer-Reviewed Original ResearchMeSH KeywordsAnti-HIV AgentsClinical Trials as TopicDrug Therapy, CombinationHIV InfectionsHumansPractice Guidelines as TopicViral LoadConceptsAdherence behaviorPlasma human immunodeficiency virus (HIV) RNA levelsHuman immunodeficiency virus (HIV) RNA levelsDrug resistanceVirus RNA levelsHIV-1 infectionDrug regimenHIV diseaseAntiretroviral treatmentViral loadTreatment regimensCombination therapyPatients' willingnessDisease progressionCostly regimensConsensus statementMore pillsPatient healthRegimensRNA levelsAdherenceDearth of informationTherapyBrief periodNonadherence
1996
Confronting the emerging HIV epidemic in Vietnam: social context and preliminary data on physician preparedness
Ha T, Ickovics J. Confronting the emerging HIV epidemic in Vietnam: social context and preliminary data on physician preparedness. AIDS 1996, 10: 1180-1181. PMID: 8874644, DOI: 10.1097/00002030-199609000-00025.Peer-Reviewed Original Research
1994
Limited effects of HIV counseling and testing for women. A prospective study of behavioral and psychological consequences.
Ickovics J, Morrill A, Beren S, Walsh U, Rodin J. Limited effects of HIV counseling and testing for women. A prospective study of behavioral and psychological consequences. JAMA 1994, 272: 443-8. PMID: 8040979, DOI: 10.1001/jama.272.6.443.Peer-Reviewed Original ResearchConceptsHIV counselingSexual riskHuman immunodeficiency virus (HIV) counselingPrimary health care servicesCommunity health clinicsHealth care servicesPartner risk factorsSeronegative womenImmunodeficiency syndromeProspective studyRisk factorsHealth clinicsPsychological consequencesStudy groupPrevention interventionsCare servicesNumber of womenCondom useGeneral psychological functioningWomenComparison groupSexual activitySequential samplesCounselingSexual behavior